These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30129266)

  • 21. [The possible causes of central pontine myelinolysis after liver transplantation].
    Yu J; Liang TB; Zheng SS; Shen Y; Wang WL; Ke QH
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1048-51. PubMed ID: 15498317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis.
    Abbasoglu O; Goldstein RM; Vodapally MS; Jennings LW; Levy MF; Husberg BS; Klintmalm GB
    Clin Transplant; 1998 Jun; 12(3):263-9. PubMed ID: 9642521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Impact of Peritransplant Serum Sodium Concentrations in Liver Transplantation.
    Mihaylov P; Nagai S; Ekser B; Mangus R; Fridell J; Kubal C
    Ann Transplant; 2019 Jul; 24():418-425. PubMed ID: 31308357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hyponatremia: the role of lixivaptan.
    Liamis G; Filippatos TD; Elisaf MS
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):431-41. PubMed ID: 24766294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current perspectives in the management of hyponatremia: prevention of CPM.
    Sterns RH; Silver S; Kleinschmidt-DeMasters BK; Rojiani AM
    Expert Rev Neurother; 2007 Dec; 7(12):1791-7. PubMed ID: 18052771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective.
    Crismale JF; Meliambro KA; DeMaria S; Bronster DB; Florman S; Schiano TD
    Am J Transplant; 2017 Oct; 17(10):2537-2545. PubMed ID: 28422408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.
    Urso C; Brucculeri S; Caimi G
    J Clin Pharm Ther; 2015 Aug; 40(4):376-85. PubMed ID: 25924179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Central pontine and extrapontine myelinolysis (review)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; Suppl 1():50-5. PubMed ID: 18927973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel intraoperative management in the model for end-stage liver disease-sodium era: Continuous venovenous hemofiltration for severe hyponatremia in liver transplantation.
    Nagai S; Moonka D; Patel A
    Liver Transpl; 2018 Feb; 24(2):304-307. PubMed ID: 29149464
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hyponatremia in liver cirrhosis: pathogenesis and treatment].
    Guevara M; Ginès P
    Endocrinol Nutr; 2010 May; 57 Suppl 2():15-21. PubMed ID: 21130958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyponatremia in cirrhosis: clinical features and management.
    Martín-Llahí M; Guevara M; Ginès P
    Gastroenterol Clin Biol; 2006 Oct; 30(10):1144-51. PubMed ID: 17075468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in the management of acute and chronic hyponatremia.
    Hoorn EJ; Spasovski G
    Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):424-432. PubMed ID: 31232710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia.
    Soupart A; Ngassa M; Decaux G
    Clin Nephrol; 1999 Jun; 51(6):383-6. PubMed ID: 10404700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of dexamethasone on osmotic-induced demyelination in rats.
    Sugimura Y; Murase T; Takefuji S; Hayasaka S; Takagishi Y; Oiso Y; Murata Y
    Exp Neurol; 2005 Mar; 192(1):178-83. PubMed ID: 15698632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hyponatremia.
    Gross P
    Intern Med; 2008; 47(10):885-91. PubMed ID: 18480571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia.
    Lohr JW
    Am J Med; 1994 May; 96(5):408-13. PubMed ID: 8192171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.
    Ginès P; Guevara M
    Hepatology; 2008 Sep; 48(3):1002-10. PubMed ID: 18671303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia.
    Soupart A; Penninckx R; Stenuit A; Decaux G
    Brain Res; 2000 Jan; 852(1):167-72. PubMed ID: 10661508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
    Ruf AE; Kremers WK; Chavez LL; Descalzi VI; Podesta LG; Villamil FG
    Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Refractory ascites and dilutional hyponatremia: current management and new aquaretics].
    Torre Delgadillo A
    Rev Gastroenterol Mex; 2005; 70(3):299-311. PubMed ID: 17063787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.